Normal mucus clearance mechanisms are impaired in many respiratory disorders. Excess bronchial secretions are most commonly associated with altered mucociliary clearance, altered mucus rheology and abnormal cough mechanics. A variety of interventions can be used to enhance mucus clearance in disorders where excess secretions cause impairment of respiratory function, including drug therapies (eg, inhaled mucolytics) and chest physiotherapy incorporating a variety of airway clearance techniques.
Chest physiotherapy plays an important part in managing respiratory disorders associated with copious, often purulent, bronchial secretions such as bronchiectasis and cystic fibrosis (CF). Airway clearance techniques, as a component of chest physiotherapy regimens, aim to enhance sputum clearance, reduce airway resistance, and improve ventilation, with the ultimate goal of delaying disease progression.
Traditionally treatment comprised the use of gravity assisted positioning (postural drainage) to 'drain' airway secretions in combination with manual physiotherapy techniques such as percussion and vibrations applied to the chest wall and interspersed with coughing. In the past 25 years the 'face' of chest physiotherapy has changed dramatically. To tackle the problems of sputum retention, several different airway clearance modalities have been developed, all of which aim to enhance abnormal mucociliary clearance, facilitate expectoration and allow independence with treatment. 1 Clinicians now have a number of options to choose from when recommending airway clearance regimens, including postural drainage, active cycle of breathing techniques, autogenic drainage, exercise, positive expiratory pressure (PEP), oscillatory PEP devices (such as the flutter, cornet, acapella), high frequency chest wall compression and intrapulmonary percussive ventilation. The majority of literature to date has examined the efficacy of these airway clearance modalities in people with cystic fibrosis. [2] [3] [4] Very few studies have considered their use in non-CF respiratory disease and it may not be appropriate to extrapolate findings from CF studies to other respiratory populations. Patterson & colleagues have in this issue reported the results of a comparison of an oscillatory PEP device (Acapella ® ) with patients' usual airway clearance regimens during an acute exacerbation of bronchiectasis 5 . Their findings showed sputum clearance, in terms of mean volume expectorated, to be significantly greater using the Acapella ® than for usual airway clearance sessions. However, there was a trend for longer duration of treatment time with this device. There were no significant 'between group' differences in lung function.
This study highlights a major problem faced by researchers when undertaking efficacy studies of airway clearance techniques; that is the lack of useful, sensitive and reliable outcome measures. The use of spirometric measurements such as FEV 1 is not ideal, not only as it may not be sufficiently sensitive to detect changes caused by sputum clearance but also the number of other confounding factors which may influence this outcome in patients with chronic respiratory disease. [6] [7] [8] There has been much debate regarding the value of sputum as an outcome measure, in terms of the timing of collection, and with regard to volume versus weight, and its real value as a valid measure of airway clearance remains questionable. 7, 8 Whether the reported increase in sputum volume with the Acapella device in this study can be attributed directly to the device used, in terms of its physiological mechanism or whether the increase is attributed to a longer treatment time and/or improved adherence due to the 'novelty' of a new device is difficult to determine.
Recently some attention has been paid to the physiological mechanisms of airway clearance modalities. 9 Achieving optimal peak expiratory flow and oscillatory frequencies in order to clear bronchial secretions effectively may be key when deciding on which device to use. Further work is needed to identify the characteristics of the various airway clearance modalities in order to gain a clearer picture of their mechanisms of action. However, also key to the issue of choosing an appropriate airway clearance regimen for any individual, is patient preference. Patterson and colleagues should be commended in their attempt to evaluate the Acapella in terms of its 'user friendliness' and patient preference between the treatment regimens. Adherence to chest physiotherapy regimens is know to be poor, particularly in chronic respiratory disease. 10, 11 An individual's perception of the efficacy of any technique and its ease of use, must surely have a significant impact on adherence to airway clearance. Attention must be paid to this both when undertaking clinical trials of airway clearance EDITORIAL Airway clearance techniques: which one?
